Literature DB >> 9224635

Tissue-specific expression and promoter analyses of the human tissue kallikrein gene in transgenic mice.

W Xiong1, J Wang, L Chao, J Chao.   

Abstract

The expression of the tissue kallikrein gene is tissue-specific and exhibits a complex pattern of transcriptional and post-translational regulation. Information concerning the mechanism of its tissue-specific expression has been limited owing to the lack of suitable cell lines for the expression study. We approached this problem by introducing human tissue kallikrein gene constructs into mouse embryos, creating transgenic lines carrying its coding sequence with varying lengths of the promoter region. One construct (PHK) contained 801 bp in the 5'-flanking region and two deletion constructs contained either 302 bp (D300) or 202 bp (D200) of the promoter region. The expression of human tissue kallikrein in these transgenic mice was monitored by Northern blot, reverse transcriptase-PCR followed by Southern blot, and radioimmunoassay. In all three lines, human tissue kallikrein was expressed predominantly in the pancreas and at lower levels in other tissues, including salivary gland, kidney and spleen. This pattern was similar to that of tissue kallikrein expression in human tissues. The D300 line has higher levels of transgene expression than the D200 and PHK lines. The results indicate that the 202 bp segment immediately upstream of the translation starting site is sufficient to direct a tissue-specific expression pattern of the human tissue kallikrein gene, and that regulatory elements might exist between -801 and -202.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9224635      PMCID: PMC1218534          DOI: 10.1042/bj3250111

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

1.  Synthesis of kallikreins by rat kidney slices.

Authors:  K Nustad; K Vaaje; J V Pierce
Journal:  Br J Pharmacol       Date:  1975-02       Impact factor: 8.739

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 3.  Kallikreins (kininogenases)--a group of serine proteases with bioregulatory actions.

Authors:  M Schachter
Journal:  Pharmacol Rev       Date:  1979-03       Impact factor: 25.468

4.  Immunohistochemical localization of glandular kallikrein in the endocrine and exocrine human pancreas.

Authors:  G S Pinkus; M Maier; D C Seldin; O K ole-MoiYoi; K F Austen; J Spragg
Journal:  J Histochem Cytochem       Date:  1983-11       Impact factor: 2.479

5.  A kininogenase resembling glandular kallikrein in the rat pituitary pars intermedia.

Authors:  C A Powers; A Nasjletti
Journal:  Endocrinology       Date:  1983-04       Impact factor: 4.736

6.  Rat submandibular gland kallikreins: purification and cellular localization.

Authors:  P Brandtzaeg; K M Gautvik; K Nustad; J V Pierce
Journal:  Br J Pharmacol       Date:  1976-02       Impact factor: 8.739

7.  The radioimmunoassay of human urinary kallikrein and comparisons with kallikrein activity measurements.

Authors:  K Shimamoto; J Chao; H S Margolius
Journal:  J Clin Endocrinol Metab       Date:  1980-10       Impact factor: 5.958

8.  Kallikrein in rat pancreatic tissue after beta cell destruction or acinar cell atrophy.

Authors:  T B Orstavik; I B Brekke; J Alumets; O A Carretero
Journal:  J Histochem Cytochem       Date:  1981-12       Impact factor: 2.479

9.  Origin of kallikrein in rat and human exocrine glands and kidney.

Authors:  T B Orstavik; K Nustad; P Brandtzaeg
Journal:  Clin Sci (Lond)       Date:  1979-12       Impact factor: 6.124

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.